Biocardia
BCDA

Biocardia (BCDA) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
HC Wainwright & Co.MaintainedBuy$25.00Aug 24, 2026
HC Wainwright & Co.MaintainedBuy$25.00Jun 9, 2026
HC Wainwright & Co.MaintainedBuy$25.00Sep 22, 2025
HC Wainwright & Co.MaintainedBuy$25.00Dec 18, 2024
HC Wainwright & Co.MaintainedBuy$25.00Nov 14, 2024
HC Wainwright & Co.MaintainedBuy$25.00Oct 28, 2024
HC Wainwright & Co.MaintainedBuy$25.00Aug 21, 2024
HC Wainwright & Co.MaintainedBuy$25.00 from $4.00Aug 16, 2024
HC Wainwright & Co.MaintainedBuy$4.00Jul 26, 2024
HC Wainwright & Co.MaintainedBuy$4.00May 29, 2024
HC Wainwright & Co.MaintainedBuy$4.00Nov 14, 2023
HC Wainwright & Co.MaintainedBuy$4.00Oct 11, 2023
HC Wainwright & Co.MaintainedBuy$4.00 from $9.00Sep 6, 2023
HC Wainwright & Co.MaintainedBuy$9.00Aug 10, 2023
HC Wainwright & Co.MaintainedBuy$9.00Jul 24, 2023
HC Wainwright & Co.MaintainedBuy$9.00Jun 21, 2023
HC Wainwright & Co.MaintainedBuy$9.00May 11, 2023

Frequently asked questions

  • What is the latest analyst rating on BCDA?

    On Aug 24, 2026, HC Wainwright & Co. maintained Biocardia at Buy with a price target of $25.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.